Correlation between risk factors for vascular disease and the American Urological Association Symptom Score

被引:22
作者
Gibbons, Erin P. [1 ]
Colen, John [1 ]
Nelson, Joel B. [1 ]
Benoit, Ronald M. [1 ]
机构
[1] Univ Pittsburgh, Dept Urol, Pittsburgh, PA USA
关键词
AUA symptom score; vascular disease; LUTS;
D O I
10.1111/j.1464-410X.2007.06548.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To evaluate the correlation between risk factors for vascular disease and the American Urological Association Symptom Score (AUA-SS), by comparing the presence of these risk factors with the degree of lower urinary tract symptoms (LUTS). PATIENTS AND METHODS We retrospectively reviewed the medical history, AUA-SS, and prostate volume of men who had a radical prostatectomy. The degree of LUTS in men with and without risk factors for cardiovascular disease was compared. RESULTS The mean AUA-SS was 7.2 for the entire cohort, 5.6 in men with no risk factors, and 7.9 in men with at least one risk factor (P < 0.05). In men with one to four risk factors, the mean AUA-SS was 6.9, 7.9, 10.7, and 19.5, respectively. There was no correlation between the AUA-SS and prostate size in the entire cohort or among any groups. CONCLUSIONS Men with risk factors for vascular disease are more likely to have a higher AUA-SS than men without these risk factors. These findings suggest the possibility of an association between vascular disease and the development and severity of LUTS in men.
引用
收藏
页码:97 / 100
页数:4
相关论文
共 24 条
[1]   RELATIONSHIP OF SYMPTOMS OF PROSTATISM TO COMMONLY USED PHYSIOLOGICAL AND ANATOMICAL MEASURES OF THE SEVERITY OF BENIGN PROSTATIC HYPERPLASIA [J].
BARRY, MJ ;
COCKETT, ATK ;
HOLTGREWE, HL ;
MCCONNELL, JD ;
SIHELNIK, SA ;
WINFIELD, HN .
JOURNAL OF UROLOGY, 1993, 150 (02) :351-358
[2]   Vascular damage as a risk factor for benign prostatic hyperplasia and erectile dysfunction [J].
Berger, AP ;
Deibl, M ;
Leonhartsberger, N ;
Bektic, J ;
Horninger, W ;
Fritsche, G ;
Steiner, H ;
Pelzer, AE ;
Bartsch, G ;
Frauscher, F .
BJU INTERNATIONAL, 2005, 96 (07) :1073-1078
[3]  
Bloch W, 1997, PROSTATE, V33, P1
[4]  
Bourke J B, 1966, Br J Urol, V38, P18, DOI 10.1111/j.1464-410X.1966.tb09675.x
[5]   NITRIC-OXIDE CONTROL OF LOWER GENITOURINARY TRACT FUNCTIONS - A REVIEW [J].
BURNETT, AL .
UROLOGY, 1995, 45 (06) :1071-1083
[6]   Incidence of acute myocardial infarction and cause-specific mortality after transurethral treatments of prostatic hypertrophy [J].
Hahn, RG ;
Farahmand, BY ;
Kallin, A ;
Hammar, N ;
Persson, PG .
UROLOGY, 2000, 55 (02) :236-240
[7]  
Hamilton W, 2004, BRIT J GEN PRACT, V54, P617
[8]  
HOPPS CV, 2003, J UROLOGY, V1689, pA4101
[9]   Natural history of benign prostatic hyperplasia [J].
Jacobsen, SJ ;
Girman, CJ ;
Lieber, MM .
UROLOGY, 2001, 58 (6A) :5-16
[10]   Nitric oxide based influence of nitrates on micturition in patients with benign prostatic hyperplasia [J].
Klotz T. ;
Mathers M.J. ;
Bloch W. ;
Nayal W. ;
Engelmann U. .
International Urology and Nephrology, 1999, 31 (3) :335-341